chemotherapy | Cancer Search

Details 61 Trials 33 Therapies

The use of synthetic or naturally-occurring chemicals for the treatment of diseases.

codes

drug

NCIt: C15632

Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)

city

177 sites for NCT04634877

condition

Endometrial Carcinoma, +1 more condition

drug

chemotherapy, +2 more drugs

drug type

chemotherapy, +2 more types

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992)

city

93 sites for NCT04241185

condition

Bladder Urothelial Carcinoma

drug

chemotherapy, +2 more drugs

drug type

chemotherapy, +2 more types

Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission

city

198 sites for NCT03267433

biomarker

CCND1 Expression, +4 more biomarkers

condition

Mantle Cell Lymphoma

drug

autologous hematopoietic stem cell transplantation, +2 more drugs

drug type

cellular therapy, +2 more types

Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma

city

71 sites for NCT03570892

biomarker

ALK Alternative Transcription Site, +7 more biomarkers

condition

ALK-Positive Large B-Cell Lymphoma, +13 more conditions

drug

chemotherapy, +1 more drug

drug type

cellular therapy, +2 more types

Tislelizumab Plus BGB-A1217 Versus Tislelizumab Versus Durvalumab When Co-administered With Concurrent Chemoradiotherapy (cCRT) in Lung Cancer

city

8 sites for NCT04866017

condition

Non-Small Cell Lung Carcinoma

drug

chemotherapy, +3 more drugs

drug type

chemotherapy, +1 more type

DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma

city

44 sites for NCT04334759

condition

Malignant Pleural Mesothelioma

drug

chemotherapy, +1 more drug

drug type

chemotherapy, +1 more type

Show 61 Trials for chemotherapy

rituximab + chemotherapy

biomarker

MS4A1 Expression

condition

Atypical Burkitt/Burkitt-Like Lymphoma, +3 more conditions

disease state

Advanced

therapeutic contexts

First line

drug

chemotherapy, +1 more drug

drug type

chemotherapy, +1 more type

pembrolizumab + chemotherapy +/- bevacizumab

biomarker

PD-L1 Expression (CPS >= 1)

condition

Cervical Carcinoma

disease state

Metastatic, +1 more state

drug

bevacizumab, +2 more drugs

drug type

chemotherapy, +2 more types

pembrolizumab + chemotherapy

biomarker

ER Negative, +2 more biomarkers

condition

Breast Carcinoma

disease state

Early stage, +1 more state

therapeutic contexts

Adjuvant, +1 more context

drug

chemotherapy, +1 more drug

drug type

chemotherapy, +1 more type

margetuximab + chemotherapy

biomarker

ERBB2 Amplification, +1 more biomarker

condition

Breast Carcinoma

disease state

Metastatic

therapeutic contexts

Subsequent line

drug

chemotherapy, +1 more drug

drug type

chemotherapy, +1 more type

pembrolizumab + chemotherapy

biomarker

PD-L1 Expression (CPS >= 10)

condition

Breast Carcinoma

disease state

Locally recurrent, +2 more states

drug

chemotherapy, +1 more drug

drug type

chemotherapy, +1 more type

pertuzumab/trastuzumab/hyaluronidase + chemotherapy

biomarker

ERBB2 Amplification, +1 more biomarker

condition

Breast Carcinoma

disease state

Early stage, +1 more state

therapeutic contexts

Neoadjuvant

drug

chemotherapy, +1 more drug

drug type

chemotherapy, +1 more type

Show 33 Therapies for chemotherapy